In the rapidly advancing field of CRISPR-based therapeutic development, the transition from Research-Use Only (RUO) to Good Manufacturing Practice (GMP) compliance presents significant challenges. Synthego’s innovative solutions are engineered specifically to address these challenges within the CRISPR RUO-to-GMP continuum. Our continuum offers unparalleled scalability, enabling researchers and developers to increase production without compromising quality. By leveraging our extensive technical and regulatory expertise, we help you mitigate the risks of delays that can hinder project timelines. Moreover, we facilitate informed decision-making by offering simplified licensing structures for CRISPR systems, crucial for successful downstream commercialization and clinical trials. With Synthego, you gain a trusted partner poised to elevate your therapeutic development aspirations.
Fly by design
Our biomanufacturing platform, the EntoEngine™, uses the common fruit fly (Drosophila melanogaster) as its protein expression system. Building on a century of genetics research, Future Fields is the first in the world to harness fruit flies for commercial recombinant protein production.
Contacts
Contact Labospace
Are you interested in our microbiome service?
We’re here to help with your project. Just complete the form when you're ready to get started.